Apogee Therapeutics Stock (NASDAQ: APGE) stock price, news, charts, stock research, profile.
Open | $40.13 |
Close | $39.35 |
Volume / Avg. | 1.94M / 449.80K |
Day Range | 38.17 - 40.83 |
52 Wk Range | 14.19 - 72.29 |
Market Cap | $2.22B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 17.66% |
Days to Cover | 19.88 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Apogee Therapeutics (NASDAQ:APGE) through any online brokerage.
Other companies in Apogee Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), PTC Therapeutics (NASDAQ:PTCT) and Protagonist Therapeutics (NASDAQ:PTGX).
There is no analysis for Apogee Therapeutics.
Apogee Therapeutics has a consensus price target of $60.57.
The stock price for Apogee Therapeutics (NASDAQ: APGE) is $39.35 last updated June 28, 2024 at 4:19 PM EDT.
There are no upcoming dividends for Apogee Therapeutics.
Apogee Therapeutics’s Q2 earnings are confirmed for Monday, August 26, 2024.
There is no upcoming split for Apogee Therapeutics.
Apogee Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.